Search Results for keywords:"National Institute on Drug Abuse"

The National Institutes of Health is holding a closed meeting for the National Institute on Drug Abuse Special Emphasis Panel on February 5, 2025. The meeting, which will be conducted virtually, aims to review and evaluate contract proposals related to the preparation and distribution of research drug products. The discussions are confidential and closed to the public to protect trade secrets and personal privacy. For additional information, individuals can contact Gagan Deep Bajaj, the Scientific Review Officer.

The National Institute on Drug Abuse announced several upcoming closed meetings. These meetings will be held virtually and are scheduled to evaluate grant applications. Participants will review confidential information, including potential trade secrets and personal details about individuals involved in the grant applications. Contact persons for each specific meeting are provided for further inquiries.

The National Institute on Drug Abuse is having a meeting on February 12, 2021, which will be closed to the public. This meeting involves the review and evaluation of contract proposals focused on health IT solutions to combat opioid misuse. The discussions at the meeting could reveal confidential information, so it will be held virtually at the National Institutes of Health. Sheila Pirooznia, Ph.D., is the Scientific Review Officer handling inquiries.

The National Institutes of Health (NIH) has announced two upcoming closed meetings of the National Institute on Drug Abuse Special Emphasis Panel. These meetings will take place on April 11 and April 30, 2025, and will focus on reviewing grant applications related to device-based treatments for substance use disorders and the relationship between stimulants and HIV. Due to confidential information being discussed, such as personal data and potential trade secrets, these meetings will not be open to the public. Both meetings will be held virtually.

The National Institute on Drug Abuse announced a closed meeting of the National Advisory Council on Drug Abuse. The meeting is scheduled for May 13, 2025, and will include sessions from 9:00 a.m. to 10:15 a.m. and from 10:15 a.m. to 10:45 a.m., conducted virtually. The agenda includes reviewing grant applications and evaluating the qualifications and performance of investigators. The discussions will be closed to the public to protect confidential information and personal privacy.

The National Institute on Drug Abuse, part of the National Institutes of Health, announced two upcoming meetings that will be closed to the public under the Federal Advisory Committee Act. The first meeting of the Special Emphasis Panel will focus on technologies for HIV and substance use disorder research and is scheduled for February 20, 2025. The second meeting, scheduled for February 28, 2025, will involve the Career Development Education and Training Study Section, both aiming to review grant applications virtually. These sessions will remain private due to the confidential nature of the discussions, which could involve sensitive personal and proprietary information.

The National Institutes of Health announced a closed meeting for the National Institute on Drug Abuse Special Emphasis Panel. This meeting, scheduled for May 2, 2025, will be conducted virtually and will review grant applications related to drug use health consequences. The meeting is closed to protect personal privacy and confidential information. Sudhirkumar U. Yanpallewar, a Scientific Review Officer, can be contacted for further information.

The National Institutes of Health, through its National Institute on Drug Abuse, has announced a closed meeting scheduled for May 5, 2025. The meeting will be held virtually and will focus on reviewing and evaluating grant applications related to neurocognitive development and addiction risk. The discussions will remain private to protect confidential information such as trade secrets and personal details of those involved in the grant process. Caitlin Elizabeth Angela Moyer, Ph.D., will serve as the contact person for further inquiries.